FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098183485> ?p ?o ?g. }

• W2098183485 endingPage "898" @default.
• W2098183485 startingPage "893" @default.
• W2098183485 abstract "Early-generation β-blockers lower blood pressure and reduce cardiovascular morality in coronary artery disease and congestive heart failure but worsen glucose homeostasis and fibrinolytic balance. Nebivolol is a third-generation β-blocker that increases the bioavailability of nitric oxide. We compared the effect of nebivolol (5 mg/d) and the β(1)-selective antagonist metoprolol (100 mg/d) on glucose homeostasis and markers of fibrinolysis in 46 subjects with metabolic syndrome. Subjects underwent a frequently sampled IV glucose tolerance test after 3-week washout and placebo treatment and after randomized treatment with study drug. After 12-week treatment, nebivolol and metoprolol equivalently decreased systolic blood pressure, diastolic blood pressure, and heart rate. Neither drug affected β-cell function, disposition index, or acute insulin response to glucose. Metoprolol significantly decreased the insulin sensitivity index. In contrast, nebivolol did not affect insulin sensitivity, and the decrease in sensitivity was significantly greater after metoprolol than after nebivolol (-1.5±2.5×10(-4)×min(-1) per milliunit per liter versus 0.04±2.19×10(-4)×min(-1) per milliunit per liter after nebivolol; P=0.03). Circulating plasminogen activator inhibitor also increased after treatment with metoprolol (from 9.8±6.8 to 12.3±7.8 ng/mL) but not nebivolol (from 10.8±7.8 to 10.5±6.2 ng/mL; P=0.05 versus metoprolol). Metoprolol, but not nebivolol, increased F(2)-isoprostane concentrations. In summary, treatment with metoprolol decreased insulin sensitivity and increased oxidative stress and the antifibrinolytic plasminogen activator inhibitor 1 in patients with metabolic syndrome, whereas nebivolol lacked detrimental metabolic effects. Large clinical trials are needed to compare effects of nebivolol and the β(1) receptor antagonist metoprolol on clinical outcomes in patients with hypertension and the metabolic syndrome." @default.
• W2098183485 created "2016-06-24" @default.
• W2098183485 creator A5015027329 @default.
• W2098183485 creator A5023128166 @default.
• W2098183485 creator A5055618165 @default.
• W2098183485 creator A5087114118 @default.
• W2098183485 date "2012-04-01" @default.
• W2098183485 modified "2023-10-12" @default.
• W2098183485 title "Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome" @default.
• W2098183485 cites W1520014993 @default.
• W2098183485 cites W1532542861 @default.
• W2098183485 cites W1561463821 @default.
• W2098183485 cites W1571937066 @default.
• W2098183485 cites W1972153352 @default.
• W2098183485 cites W1977607782 @default.
• W2098183485 cites W1977797609 @default.
• W2098183485 cites W1984595407 @default.
• W2098183485 cites W1992631970 @default.
• W2098183485 cites W1996940198 @default.
• W2098183485 cites W2007499677 @default.
• W2098183485 cites W2009760859 @default.
• W2098183485 cites W2012115218 @default.
• W2098183485 cites W2014625989 @default.
• W2098183485 cites W2015771736 @default.
• W2098183485 cites W2017966192 @default.
• W2098183485 cites W2025067229 @default.
• W2098183485 cites W2031813397 @default.
• W2098183485 cites W2041830601 @default.
• W2098183485 cites W2049263276 @default.
• W2098183485 cites W2052326847 @default.
• W2098183485 cites W2060449981 @default.
• W2098183485 cites W2070717530 @default.
• W2098183485 cites W2080667729 @default.
• W2098183485 cites W2083575326 @default.
• W2098183485 cites W2094943016 @default.
• W2098183485 cites W2097996074 @default.
• W2098183485 cites W2111673757 @default.
• W2098183485 cites W2114333967 @default.
• W2098183485 cites W2126412451 @default.
• W2098183485 cites W2137725928 @default.
• W2098183485 cites W2143752363 @default.
• W2098183485 cites W2154570146 @default.
• W2098183485 cites W2157978193 @default.
• W2098183485 cites W2161392015 @default.
• W2098183485 cites W2164632621 @default.
• W2098183485 cites W2319368155 @default.
• W2098183485 doi "https://doi.org/10.1161/hypertensionaha.111.189589" @default.
• W2098183485 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3402551" @default.
• W2098183485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22353614" @default.
• W2098183485 hasPublicationYear "2012" @default.
• W2098183485 type Work @default.
• W2098183485 sameAs 2098183485 @default.
• W2098183485 citedByCount "65" @default.
• W2098183485 countsByYear W20981834852013 @default.
• W2098183485 countsByYear W20981834852014 @default.
• W2098183485 countsByYear W20981834852015 @default.
• W2098183485 countsByYear W20981834852016 @default.
• W2098183485 countsByYear W20981834852017 @default.
• W2098183485 countsByYear W20981834852018 @default.
• W2098183485 countsByYear W20981834852019 @default.
• W2098183485 countsByYear W20981834852020 @default.
• W2098183485 countsByYear W20981834852021 @default.
• W2098183485 countsByYear W20981834852022 @default.
• W2098183485 countsByYear W20981834852023 @default.
• W2098183485 crossrefType "journal-article" @default.
• W2098183485 hasAuthorship W2098183485A5015027329 @default.
• W2098183485 hasAuthorship W2098183485A5023128166 @default.
• W2098183485 hasAuthorship W2098183485A5055618165 @default.
• W2098183485 hasAuthorship W2098183485A5087114118 @default.
• W2098183485 hasBestOaLocation W20981834851 @default.
• W2098183485 hasConcept C126322002 @default.
• W2098183485 hasConcept C134018914 @default.
• W2098183485 hasConcept C2777391703 @default.
• W2098183485 hasConcept C2777537511 @default.
• W2098183485 hasConcept C2778535154 @default.
• W2098183485 hasConcept C2779306644 @default.
• W2098183485 hasConcept C2781280847 @default.
• W2098183485 hasConcept C71924100 @default.
• W2098183485 hasConcept C84393581 @default.
• W2098183485 hasConceptScore W2098183485C126322002 @default.
• W2098183485 hasConceptScore W2098183485C134018914 @default.
• W2098183485 hasConceptScore W2098183485C2777391703 @default.
• W2098183485 hasConceptScore W2098183485C2777537511 @default.
• W2098183485 hasConceptScore W2098183485C2778535154 @default.
• W2098183485 hasConceptScore W2098183485C2779306644 @default.
• W2098183485 hasConceptScore W2098183485C2781280847 @default.
• W2098183485 hasConceptScore W2098183485C71924100 @default.
• W2098183485 hasConceptScore W2098183485C84393581 @default.
• W2098183485 hasIssue "4" @default.
• W2098183485 hasLocation W20981834851 @default.
• W2098183485 hasLocation W20981834852 @default.
• W2098183485 hasLocation W20981834853 @default.
• W2098183485 hasLocation W20981834854 @default.
• W2098183485 hasOpenAccess W2098183485 @default.
• W2098183485 hasPrimaryLocation W20981834851 @default.
• W2098183485 hasRelatedWork W138803513 @default.
• W2098183485 hasRelatedWork W1986132654 @default.
• W2098183485 hasRelatedWork W2010140898 @default.

• next